Provides digital chronic-disease management programs (diabetes, hypertension, musculoskeletal) via app and health coaching for employers and health plans.
Provides digital chronic-disease management programs (diabetes, hypertension, musculoskeletal) via app and health coaching for employers and health plans.
Is paid by employers and health plans rather than by the patient, mainly as a fee per enrolled member, with part of the fee tied to health results. It added support for patients taking GLP-1 weight-loss drugs, and went public in 2025.
Moat: narrow (data, customer qualification, installed base). Clinical outcomes data and embedded employer/health-plan contracts create switching costs versus newer entrants.
Headquarters: San Francisco, California, United States · Founded: 2011 · Employees: 916
Size Omada Health (OMDA) is a United States Information Technology company (Internet Software/Services) with a market value of $817M, the 2356th largest of 3,085 United States companies the cockpit tracks. Shares closed at $13.17 on 18 Nov 2026.
Performance Over six months the shares fell 20.3%, against -2.5% for the median peer and -2.2% for the United States market (cap-weighted) — 8th lowest of 21 in its peer set.
Growth Revenue grew 43.3% over the last twelve months (peer median +10.4%); the operating margin is 2.1% (peer median 9.2%).
Valuation It trades at 28.3× forward earnings against a peer median of 14.3× (6th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 44% a year for seven years (Req g). Recent delivered growth is +43%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.4 points above its cost of capital (15.7% WACC).
Short interest Short interest is 14.8% of the free float (30 Oct 2026).
Next results Next results expected around 11 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $333M | $260M | $170M | $123M | $89.2M |
| Revenue growth | — | +53% | +38% | +38% | — |
| Gross profit | $235M | $170M | $102M | $69.3M | $42.0M |
| EBITDA | $13.1M | -$6.48M | -$38.9M | -$61.5M | -$68.0M |
| Net income | $14.0M | -$12.8M | -$47.1M | -$67.5M | -$72.5M |
| Free cash flow | $28.2M | $16.9M | -$34.8M | -$50.2M | -$68.4M |
| Capital expenditure | $6.20M | $5.83M | $3.86M | $2.92M | $2.72M |
| Total debt | $0 | $0 | $30.2M | $30.6M | $30.8M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Omada Health OMDA | $817M | -20% | +43% | 2% | 28.3× | 44.4% |
| Teladoc Health TDOC | $1.47B | +24% | -2% | -5% | n/a | -6.4% |
| Hinge Health HNGE | $9.31B | +109% | +50% | 19% | 39.2× | 34.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | OMDA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -31.9% | -2.9% | 3rd lowest of 21 |
| 6-month return | -20.3% | -2.5% | 8th lowest of 21 |
| Distance from 52-week high | -48.2% | -36.3% | 6th lowest of 21 |
| Revenue growth (TTM) | +43.3% | +10.4% | 3rd highest of 21 |
| Operating margin | 2.1% | 9.2% | 8th lowest of 21 |
| Forward P/E | 28.3× | 14.3× | 6th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 44.4% | 3.5% | 2nd most demanding of 14 |
| Growth delivered (Del g) | +42.9% | +15.9% | 3rd highest of 14 |
| Hurdle (Req g minus delivered) | +1.5 pp | -11.0 pp | 3rd most demanding of 14 |
| ROIC minus cost of capital | +2.4 pp | +0.1 pp | 9th highest of 19 |
| Net debt / EBITDA | -18.6× | -0.4× | 2nd least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Omada Health OMDA | United States | $817M | -20% | +43% | 2% | 28.3× | 44.4% | +42.9% |
| Gushengtang 2273.HK | Hong Kong | $828M | +2% | +12% | 13% | 12.7× | 1.8% | +27.6% |
| Le Travenues Technology IXIGO.NS | India | $834M | +9% | +16% | 6% | 50.5× | 40.0% | +55.4% |
| TeamViewer TMV.DE | Germany | $786M | -20% | +2% | 34% | 4.7× | -12.0% | +10.4% |
| Nextdoor NXDR | United States | $774M | -3% | +12% | -11% | 85.0× | 4.8% | +15.9% |
| Yalla Group Ltd. Sponsored ADR YALA | United States | $872M | -2% | -4% | 28% | 7.9× | n/a | n/a |
| BuySell Technologies 7685.T | Japan | $881M | -34% | +52% | 11% | 14.3× | -3.6% | +46.8% |
| Phoenix Education Partners PXED | United States | $754M | -28% | +1% | 17% | 5.2× | n/a | n/a |
| LegalZoom.com LZ | United States | $748M | -30% | +10% | 6% | 6.5× | -0.3% | +9.9% |
| FuboTV FUBO | United States | $735M | -27% | +276% | -2% | n/a | n/a | n/a |
| Sify Technologies Limited Sponsored ADR SIFY | United States | $918M | -23% | +11% | 8% | n/a | n/a | n/a |
| Auction Technology ATG.L | United Kingdom | $720M | +12% | +22% | 11% | 15.0× | 21.7% | +32.6% |
| PubMatic PUBM | United States | $947M | +92% | +4% | 2% | 105.3× | 46.0% | +13.7% |
| iQIYI, Inc. Sponsored ADR IQ | United States | $682M | -46% | -2% | -1% | n/a | n/a | n/a |
| D-MARKET Elektronik Hizmetler ve Ticaret AS Sponsored ADR HEPS | United States | $982M | 0% | +15% | -3% | n/a | n/a | n/a |
| Cars.com CARS | United States | $677M | +33% | +1% | 13% | 5.7× | 3.0% | +5.7% |
| EverQuote EVER | United States | $1.00B | +51% | +24% | 11% | 14.3× | -7.1% | +14.8% |
| Baltic Classifieds BCG.L | United Kingdom | $1.05B | -99% | +7% | 68% | 0.2× | 14.5% | +15.9% |
| SiteMinder SDR.AX | Australia | $626M | +16% | +19% | -2% | 92.3× | 21.3% | +21.4% |
| Moonpig MOON.L | United Kingdom | $1.08B | +33% | +7% | 21% | 14.9× | 3.5% | +0.3% |
| Digital Garage 4819.T | Japan | $615M | -10% | +2% | -7% | 313.1× | n/a | n/a |